Andreas Bakker

880 total citations
9 papers, 742 citations indexed

About

Andreas Bakker is a scholar working on Virology, Immunology and Molecular Biology. According to data from OpenAlex, Andreas Bakker has authored 9 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Virology, 5 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Andreas Bakker's work include HIV Research and Treatment (5 papers), T-cell and Retrovirus Studies (3 papers) and Animal Disease Management and Epidemiology (2 papers). Andreas Bakker is often cited by papers focused on HIV Research and Treatment (5 papers), T-cell and Retrovirus Studies (3 papers) and Animal Disease Management and Epidemiology (2 papers). Andreas Bakker collaborates with scholars based in United States, Croatia and Belgium. Andreas Bakker's co-authors include Ronald T. Mitsuyasu, Margo R. Roberts, Kristen Hege, Matthew Downs, Steven G. Deeks, Carl H. June, David T. Scadden, Elizabeth Connick, Andy Lin and Peter A. Anton and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The FASEB Journal.

In The Last Decade

Andreas Bakker

8 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Bakker United States 7 398 307 289 281 216 9 742
R M Hesselton United States 11 129 0.3× 126 0.4× 183 0.6× 389 1.4× 134 0.6× 13 710
Nadine Bizouarne France 12 338 0.8× 407 1.3× 229 0.8× 567 2.0× 66 0.3× 17 834
Roshni Ravindranathan United States 12 805 2.0× 337 1.1× 727 2.5× 432 1.5× 47 0.2× 17 1.1k
Yanal Murad Canada 14 166 0.4× 226 0.7× 108 0.4× 209 0.7× 57 0.3× 26 583
Hanna Dreja United Kingdom 13 143 0.4× 399 1.3× 197 0.7× 438 1.6× 132 0.6× 24 818
Andrew Fedanov United States 11 209 0.5× 105 0.3× 67 0.2× 278 1.0× 212 1.0× 15 575
William Shingler United Kingdom 13 380 1.0× 191 0.6× 149 0.5× 435 1.5× 62 0.3× 26 697
Christine E. Engeland Germany 18 674 1.7× 385 1.3× 792 2.7× 257 0.9× 39 0.2× 38 1.1k
Ekaterini Kotsopoulou United Kingdom 11 193 0.5× 329 1.1× 178 0.6× 63 0.2× 87 0.4× 13 507

Countries citing papers authored by Andreas Bakker

Since Specialization
Citations

This map shows the geographic impact of Andreas Bakker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Bakker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Bakker more than expected).

Fields of papers citing papers by Andreas Bakker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Bakker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Bakker. The network helps show where Andreas Bakker may publish in the future.

Co-authorship network of co-authors of Andreas Bakker

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Bakker. A scholar is included among the top collaborators of Andreas Bakker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Bakker. Andreas Bakker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Oliner, Kelly S., Todd Juan, Sid Suggs, et al.. (2010). A comparability study of 5 commercial KRAS tests. Diagnostic Pathology. 5(1). 23–23. 44 indexed citations
2.
Patterson, Scott D., Kelly S. Oliner, Daniel J. Freeman, et al.. (2009). Comparability testing of KRAS mutations and association with efficacy from a phase 3 randomized trial of panitumumab (pmab). The FASEB Journal. 23(S1).
3.
Amado, Rafael G., Ronald T. Mitsuyasu, Joseph D. Rosenblatt, et al.. (2004). Anti-Human Immunodeficiency Virus Hematopoietic Progenitor Cell-Delivered Ribozyme in a Phase I Study: Myeloid and Lymphoid Reconstitution in Human Immunodeficiency Virus Type-1–Infected Patients. Human Gene Therapy. 15(3). 251–262. 113 indexed citations
4.
Mitsuyasu, Ronald T., Peter A. Anton, Steven G. Deeks, et al.. (2000). Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus–infected subjects. Blood. 96(3). 785–793. 186 indexed citations
5.
Mitsuyasu, Ronald T., Peter A. Anton, Steven G. Deeks, et al.. (2000). Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus–infected subjects. Blood. 96(3). 785–793. 335 indexed citations
6.
Lu, Yuanan, Vicente Planelles, Chockalingam Palaniappan, et al.. (1997). Inhibition of HIV-1 Replication Using a Mutated tRNALys-3 Primer. Journal of Biological Chemistry. 272(23). 14523–14531. 15 indexed citations
7.
Rosenblatt, Joseph D., et al.. (1996). Negative Regulation of Gene Expression from the HTLV Type II Long Terminal Repeat by Rex: Functional and Structural Dissociation from Positive Posttranscriptional Regulation. AIDS Research and Human Retroviruses. 12(6). 535–546. 6 indexed citations
8.
Luo, Jie, et al.. (1996). Specific binding of polypyrimidine tract binding protein and hnRNP A1 to HIV-1 CRS elements. Virus Genes. 12(3). 275–85. 33 indexed citations
9.
Luo, Jie, et al.. (1994). Binding of Nuclear Proteins to HTLV-II cis-Acting Repressive Sequence (CRS) RNA Correlates with CRS Function. Virology. 200(1). 29–41. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026